Ontology type: schema:ScholarlyArticle Open Access: True
2008-04
AUTHORSHirofumi Makino, Masakazu Haneda, Tetsuya Babazono, Tatsumi Moriya, Sadayoshi Ito, Yasuhiko Iwamoto, Ryuzo Kawamori, Masahiro Takeuchi, Shigehiro Katayama
ABSTRACTThe Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study previously showed that treatment with telmisartan, an angiotensin II receptor blocker, effectively reduced the transition from incipient to overt nephropathy in Japanese type 2 diabetic patients. However, that large study included both normotensive and hypertensive patients. In the present post hoc analysis, we aimed to assess whether or not telmisartan elicits beneficial effects on the progression of microalbuminuria in normotensive patients. We randomized 163 microalbuminuric (urinary albumin-to-creatinine ratio: UACR of 100 to 300 mg/g creatinine) normotensive type 2 diabetic patients to treatment with telmisartan (40 or 80 mg once daily) or placebo over 52 weeks. The patients treated with either dose of telmisartan showed lower transition rates from microalbuminuria to overt nephropathy compared to the placebo group. In addition, more patients on telmisartan reverted to normoalbuminuria (UACR<30 mg/g creatinine): 15.5% of the 40 mg group, 19.6% of the 80 mg group, and 1.9% of the placebo group. In normotensive patients treated with telmisartan, changes in UACR were not significantly correlated with changes in blood pressure. Side effects did not differ among the groups. The present study demonstrates that telmisartan prevents the progression of microalbuminuria (in some cases induces remission of albuminuria) in normotensive Japanese patients with type 2 diabetes. Telmisartan is shown to be safe and well tolerated in these patients. More... »
PAGEShr200888
http://scigraph.springernature.com/pub.10.1291/hypres.31.657
DOIhttp://dx.doi.org/10.1291/hypres.31.657
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1029252385
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/18633177
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Albuminuria",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Angiotensin II Type 1 Receptor Blockers",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Benzimidazoles",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Benzoates",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Blood Pressure",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Diabetes Mellitus, Type 2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Diabetic Nephropathies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease Progression",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hypertension, Renal",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Japan",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Okayama University",
"id": "https://www.grid.ac/institutes/grid.261356.5",
"name": [
"Department of Medicine and Clinical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"
],
"type": "Organization"
},
"familyName": "Makino",
"givenName": "Hirofumi",
"id": "sg:person.01326213552.92",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326213552.92"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Asahikawa Medical University",
"id": "https://www.grid.ac/institutes/grid.252427.4",
"name": [
"Division of Metabolism and Biosystemic Science, Asahikawa Medical College, Asahikawa, Japan"
],
"type": "Organization"
},
"familyName": "Haneda",
"givenName": "Masakazu",
"id": "sg:person.01342044323.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342044323.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tokyo Women's Medical University",
"id": "https://www.grid.ac/institutes/grid.410818.4",
"name": [
"Division of Nephrology and Hypertension, Tokyo Women's Medical University School of Medicine, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Babazono",
"givenName": "Tetsuya",
"id": "sg:person.01321777414.49",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321777414.49"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Kitasato University",
"id": "https://www.grid.ac/institutes/grid.410786.c",
"name": [
"Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine, Sagamihara, Japan"
],
"type": "Organization"
},
"familyName": "Moriya",
"givenName": "Tatsumi",
"id": "sg:person.01335146610.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335146610.54"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tohoku University",
"id": "https://www.grid.ac/institutes/grid.69566.3a",
"name": [
"Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan"
],
"type": "Organization"
},
"familyName": "Ito",
"givenName": "Sadayoshi",
"id": "sg:person.016364606112.97",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016364606112.97"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Tokyo Women's Medical University",
"id": "https://www.grid.ac/institutes/grid.410818.4",
"name": [
"Department of Medicine, Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Iwamoto",
"givenName": "Yasuhiko",
"id": "sg:person.01112675036.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112675036.11"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Juntendo University",
"id": "https://www.grid.ac/institutes/grid.258269.2",
"name": [
"Department of Medicine, Metabolism and Endocrinology, School of Medicine, Juntendo University, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Kawamori",
"givenName": "Ryuzo",
"id": "sg:person.0653767313.41",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653767313.41"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Kitasato University",
"id": "https://www.grid.ac/institutes/grid.410786.c",
"name": [
"Division of Biostatistics, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Takeuchi",
"givenName": "Masahiro",
"id": "sg:person.01051540664.64",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051540664.64"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Saitama University",
"id": "https://www.grid.ac/institutes/grid.263023.6",
"name": [
"Division of Endocrinology and Diabetes, Department of Medicine, Saitama Medical School, Saitama, Japan"
],
"type": "Organization"
},
"familyName": "Katayama",
"givenName": "Shigehiro",
"id": "sg:person.0677412362.35",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677412362.35"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.2337/diacare.25.11.1909",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000282518"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/archinte.163.13.1555",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007918576"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2337/diacare.23.12.1823",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008519867"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jama.289.19.2560",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1013958161"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa042167",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014827479"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11892-005-0013-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015803331",
"https://doi.org/10.1007/s11892-005-0013-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1046/j.1523-1755.2001.00790.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016222610",
"https://doi.org/10.1046/j.1523-1755.2001.00790.x"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2337/dc06-0003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017335475"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1161/01.cir.0000024416.33113.0a",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018363188"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11906-001-0068-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018371956",
"https://doi.org/10.1007/s11906-001-0068-9"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1161/01.hyp.0000154082.72286.2a",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019798092"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1161/01.hyp.0000154082.72286.2a",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019798092"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.ki.5000377",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021627411",
"https://doi.org/10.1038/sj.ki.5000377"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1177/147323000503300610",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023218624"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1177/147323000503300610",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023218624"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1291/hypres.29.143",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026903818",
"https://doi.org/10.1291/hypres.29.143"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2350-7-42",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027587645",
"https://doi.org/10.1186/1471-2350-7-42"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1161/01.cir.0000139860.33974.28",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029162260"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1291/hypres.30.325",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031099181",
"https://doi.org/10.1291/hypres.30.325"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa011489",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032755890"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(05)67814-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034871716"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1291/hypres.26.515",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040472493",
"https://doi.org/10.1291/hypres.26.515"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1161/circulationaha.106.179294",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1043969273"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa042274",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044370192"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2337/dc06-1998",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046307720"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0828-282x(06)70280-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051904993"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1111/j.1523-1755.2005.00511.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053471411",
"https://doi.org/10.1111/j.1523-1755.2005.00511.x"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1523-1755.2005.00511.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053471411"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jama.271.4.275",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1054157122"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1291/hypres.29.s1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064749255"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.7326/0003-4819-139-2-200307150-00008",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1073706422"
],
"type": "CreativeWork"
}
],
"datePublished": "2008-04",
"datePublishedReg": "2008-04-01",
"description": "The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study previously showed that treatment with telmisartan, an angiotensin II receptor blocker, effectively reduced the transition from incipient to overt nephropathy in Japanese type 2 diabetic patients. However, that large study included both normotensive and hypertensive patients. In the present post hoc analysis, we aimed to assess whether or not telmisartan elicits beneficial effects on the progression of microalbuminuria in normotensive patients. We randomized 163 microalbuminuric (urinary albumin-to-creatinine ratio: UACR of 100 to 300 mg/g creatinine) normotensive type 2 diabetic patients to treatment with telmisartan (40 or 80 mg once daily) or placebo over 52 weeks. The patients treated with either dose of telmisartan showed lower transition rates from microalbuminuria to overt nephropathy compared to the placebo group. In addition, more patients on telmisartan reverted to normoalbuminuria (UACR<30 mg/g creatinine): 15.5% of the 40 mg group, 19.6% of the 80 mg group, and 1.9% of the placebo group. In normotensive patients treated with telmisartan, changes in UACR were not significantly correlated with changes in blood pressure. Side effects did not differ among the groups. The present study demonstrates that telmisartan prevents the progression of microalbuminuria (in some cases induces remission of albuminuria) in normotensive Japanese patients with type 2 diabetes. Telmisartan is shown to be safe and well tolerated in these patients.",
"genre": "research_article",
"id": "sg:pub.10.1291/hypres.31.657",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1313717",
"issn": [
"0916-9636",
"1348-4214"
],
"name": "Hypertension Research",
"type": "Periodical"
},
{
"issueNumber": "4",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "31"
}
],
"name": "Microalbuminuria Reduction with Telmisartan in Normotensive and Hypertensive Japanese Patients with Type 2 Diabetes: A Post-Hoc Analysis of the Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study",
"pagination": "hr200888",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"8b5ac7f841a6331287798a92520504fa3111d33adcede1c3d05c36e8c89b4285"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"18633177"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9307690"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1291/hypres.31.657"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1029252385"
]
}
],
"sameAs": [
"https://doi.org/10.1291/hypres.31.657",
"https://app.dimensions.ai/details/publication/pub.1029252385"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T23:12",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000425.jsonl",
"type": "ScholarlyArticle",
"url": "http://www.nature.com/articles/hr200888"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1291/hypres.31.657'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1291/hypres.31.657'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1291/hypres.31.657'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1291/hypres.31.657'
This table displays all metadata directly associated to this object as RDF triples.
301 TRIPLES
21 PREDICATES
73 URIs
36 LITERALS
24 BLANK NODES